Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.55 USD | -1.08% | +0.52% | -41.85% |
May. 29 | Truist Securities Lowers Price Target on Cytokinetics to $70 From $86, Maintains Buy Rating | MT |
May. 28 | Cytokinetics Closes $500 Million Stock Offering | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.85% | 5.57B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.03% | 21.96B | |
-8.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- Needham Adjusts Price Target on Cytokinetics to $60 From $58, Maintains Buy Rating